A novel protein cRERE encoded by a circular RNA directly targets ERK signaling to alleviate chemotherapy-induced neuropathic pain
- PMID: 41107944
- DOI: 10.1186/s12964-025-02455-x
A novel protein cRERE encoded by a circular RNA directly targets ERK signaling to alleviate chemotherapy-induced neuropathic pain
Abstract
Circular RNAs (circRNAs), as stable and evolutionarily conserved epigenetic regulators, have attracted growing attention, especially those enriched in the central nervous system (CNS). CNS-specific circRNAs downregulated during disease progression are increasingly recognized as potential therapeutic targets. The clinical translation of circRNAs for stroke treatment further supports the feasibility of circRNA-based therapies, raising the question of whether certain circRNAs may also modulate chemotherapy-induced neuropathic pain (CINP). In this study, we report the identification of a dorsal horn-specific circRere, which is significantly downregulated following vincristine (VCR) administration. Mechanistically, circRere encodes a novel protein, cRERE, in an N6-methyladenosine (m6A)-dependent manner. cRERE alleviates CINP by spatially interfering with the phosphorylation activation site of extracellular signal-regulated kinase 1 (ERK1), thereby preventing downstream activation of the CREB/IL-1β signaling cascade. Taken together, our findings reveal that circRere exerts analgesic effects via an unconventional translation mechanism that generates a functional protein. This study highlights the therapeutic potential of targeting disease-specific downregulated circRNAs and their encoded endogenous proteins for the treatment of CINP.
Keywords: CircRNA; Coding function; Neuropathic pain; Signaling pathway; Spinal dorsal horn.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study complies with the guidelines for animal care and ethical treatment of the National Institutes of Health in the United States, and all experimental procedures have been approved by the Experimental Animal Committee of Sun Yat-sen University. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
References
-
- Uittenboogaard A, Neutel CLG, Ket JCF, Njuguna F, Huitema ADR, Kaspers GJL, et al. Pharmacogenomics of vincristine-induced peripheral neuropathy in children with cancer: a systematic review and meta-analysis. Cancers (Basel). 2022. https://doi.org/10.3390/cancers14030612 . - DOI - PubMed
-
- Triarico S, Romano A, Attina G, Capozza MA, Maurizi P, Mastrangelo S, et al. Vincristine-induced peripheral neuropathy (VIPN) in pediatric tumors: mechanisms, risk factors, strategies of prevention and treatment. Int J Mol Sci. 2021. https://doi.org/10.3390/ijms22084112 . - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
- 2023A03J0408/Science and Technology Program of Guangzhou
- 2023013/Scientific Research Projects of Medical and Health Institutions of Longhua District, Shenzhen
- 2022A1515012124/Guangdong Basic and Applied Basic Research Foundation
- 2024A1515011398/Guangdong Basic and Applied Basic Research Foundation
- 2022B1515120026/Guangdong Basic and Applied Basic Research Foundation
- 2023A1515030020/Guangdong Basic and Applied Basic Research Foundation
- 2023B0303010002/Guangdong Province Key Field R&D Plan Project
- 20226060004/Guangzhou Science and Technology Plan Project
- 2023B1212060018/Science and Technology Planning Project of Guangdong Province
- 82572936/This study was supported by National Natural Science Foundation of China
- 82572936/This study was supported by National Natural Science Foundation of China